rs3789806

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_004333.6(BRAF):​c.1992+16G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.176 in 1,609,598 control chromosomes in the GnomAD database, including 37,044 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.30 ( 10808 hom., cov: 32)
Exomes 𝑓: 0.16 ( 26236 hom. )

Consequence

BRAF
NM_004333.6 intron

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:9O:1

Conservation

PhyloP100: 0.313

Publications

17 publications found
Variant links:
Genes affected
BRAF (HGNC:1097): (B-Raf proto-oncogene, serine/threonine kinase) This gene encodes a protein belonging to the RAF family of serine/threonine protein kinases. This protein plays a role in regulating the MAP kinase/ERK signaling pathway, which affects cell division, differentiation, and secretion. Mutations in this gene, most commonly the V600E mutation, are the most frequently identified cancer-causing mutations in melanoma, and have been identified in various other cancers as well, including non-Hodgkin lymphoma, colorectal cancer, thyroid carcinoma, non-small cell lung carcinoma, hairy cell leukemia and adenocarcinoma of lung. Mutations in this gene are also associated with cardiofaciocutaneous, Noonan, and Costello syndromes, which exhibit overlapping phenotypes. A pseudogene of this gene has been identified on the X chromosome. [provided by RefSeq, Aug 2017]
BRAF Gene-Disease associations (from GenCC):
  • cardiofaciocutaneous syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • cardiofaciocutaneous syndrome 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • LEOPARD syndrome 3
    Inheritance: AD Classification: DEFINITIVE, STRONG, LIMITED Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • Noonan syndrome 7
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp, Ambry Genetics
  • Noonan syndrome
    Inheritance: AD Classification: MODERATE Submitted by: ClinGen
  • Noonan syndrome with multiple lentigines
    Inheritance: AD Classification: SUPPORTIVE, LIMITED Submitted by: ClinGen, Orphanet
  • anaplastic astrocytoma
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • Costello syndrome
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
  • Noonan syndrome-like disorder with loose anagen hair
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 7-140749271-C-G is Benign according to our data. Variant chr7-140749271-C-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 40393.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.658 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004333.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BRAF
NM_001374258.1
MANE Plus Clinical
c.2112+16G>C
intron
N/ANP_001361187.1A0A2R8Y8E0
BRAF
NM_004333.6
MANE Select
c.1992+16G>C
intron
N/ANP_004324.2
BRAF
NM_001374244.1
c.2112+16G>C
intron
N/ANP_001361173.1A0A2U3TZI2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BRAF
ENST00000644969.2
MANE Plus Clinical
c.2112+16G>C
intron
N/AENSP00000496776.1A0A2R8Y8E0
BRAF
ENST00000646891.2
MANE Select
c.1992+16G>C
intron
N/AENSP00000493543.1P15056
BRAF
ENST00000288602.11
TSL:1
c.2112+16G>C
intron
N/AENSP00000288602.7A0A2U3TZI2

Frequencies

GnomAD3 genomes
AF:
0.298
AC:
45280
AN:
151876
Hom.:
10759
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.664
Gnomad AMI
AF:
0.104
Gnomad AMR
AF:
0.181
Gnomad ASJ
AF:
0.198
Gnomad EAS
AF:
0.174
Gnomad SAS
AF:
0.310
Gnomad FIN
AF:
0.153
Gnomad MID
AF:
0.304
Gnomad NFE
AF:
0.142
Gnomad OTH
AF:
0.267
GnomAD2 exomes
AF:
0.199
AC:
49747
AN:
250290
AF XY:
0.199
show subpopulations
Gnomad AFR exome
AF:
0.674
Gnomad AMR exome
AF:
0.0994
Gnomad ASJ exome
AF:
0.205
Gnomad EAS exome
AF:
0.186
Gnomad FIN exome
AF:
0.149
Gnomad NFE exome
AF:
0.142
Gnomad OTH exome
AF:
0.179
GnomAD4 exome
AF:
0.163
AC:
237989
AN:
1457604
Hom.:
26236
Cov.:
32
AF XY:
0.167
AC XY:
121127
AN XY:
725174
show subpopulations
African (AFR)
AF:
0.680
AC:
22655
AN:
33324
American (AMR)
AF:
0.109
AC:
4878
AN:
44640
Ashkenazi Jewish (ASJ)
AF:
0.206
AC:
5361
AN:
26064
East Asian (EAS)
AF:
0.156
AC:
6159
AN:
39540
South Asian (SAS)
AF:
0.313
AC:
26966
AN:
86054
European-Finnish (FIN)
AF:
0.142
AC:
7570
AN:
53248
Middle Eastern (MID)
AF:
0.283
AC:
1175
AN:
4146
European-Non Finnish (NFE)
AF:
0.136
AC:
151504
AN:
1110504
Other (OTH)
AF:
0.195
AC:
11721
AN:
60084
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.460
Heterozygous variant carriers
0
9258
18516
27775
37033
46291
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
5748
11496
17244
22992
28740
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.299
AC:
45378
AN:
151994
Hom.:
10808
Cov.:
32
AF XY:
0.296
AC XY:
21990
AN XY:
74278
show subpopulations
African (AFR)
AF:
0.665
AC:
27556
AN:
41456
American (AMR)
AF:
0.180
AC:
2753
AN:
15266
Ashkenazi Jewish (ASJ)
AF:
0.198
AC:
687
AN:
3468
East Asian (EAS)
AF:
0.174
AC:
900
AN:
5168
South Asian (SAS)
AF:
0.309
AC:
1488
AN:
4818
European-Finnish (FIN)
AF:
0.153
AC:
1612
AN:
10568
Middle Eastern (MID)
AF:
0.306
AC:
90
AN:
294
European-Non Finnish (NFE)
AF:
0.142
AC:
9632
AN:
67936
Other (OTH)
AF:
0.268
AC:
565
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1203
2405
3608
4810
6013
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
402
804
1206
1608
2010
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.125
Hom.:
340
Bravo
AF:
0.312
Asia WGS
AF:
0.280
AC:
974
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
5
not specified (5)
-
-
2
RASopathy (2)
-
-
1
Lung cancer;C0346629:Colorectal cancer;C1835047:Melanoma, cutaneous malignant, susceptibility to, 1;C3150970:Noonan syndrome 7;C3150971:LEOPARD syndrome 3;C4551602:Noonan syndrome 1;CN029449:Cardiofaciocutaneous syndrome 1 (1)
-
-
1
not provided (2)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
12
DANN
Benign
0.50
PhyloP100
0.31
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3789806; hg19: chr7-140449071; COSMIC: COSV56062530; API